Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Central Asia faces a critical knowledge gap when it comes to cognitive decline and dementia. While current epidemiological data suggests that dementia carries a lower disease burden in Central Asia compared to East or Southeast Asia, this apparent advantage may be misleading—the region’s severely limited research infrastructure likely means that actual prevalence rates are significantly underestimated.
What we know with certainty is that across Asia broadly, including Central Asia, dementia is projected to increase substantially over the next three decades, and policymakers in the region are increasingly recognizing that “bold adaptive action” is required to prevent a crisis of care. This article examines what research actually reveals about cognitive decline and dementia in Central Asia, why the region remains understudied, and what policy and clinical responses are already overdue. You’ll learn how Central Asia’s dementia burden compares to neighboring regions, why prevention and early diagnosis are more critical now than ever, and what healthcare systems must do to prepare for demographic shifts that will strain existing services.
Table of Contents
- Why Is Central Asia’s Dementia Research So Limited?
- How Does Central Asia’s Dementia Burden Rank Among Other Neurological Conditions?
- What Demographic and Health Factors Drive Dementia Growth Across Asia?
- What Policy Changes Are Essential to Address Cognitive Decline?
- What Challenges Do Central Asian Healthcare Systems Face in Diagnosing Dementia?
- How Can Prevention and Lifestyle Factors Reduce Dementia Risk?
- What Should Central Asia Anticipate in the Coming Decades?
- Conclusion
Why Is Central Asia’s Dementia Research So Limited?
Central Asia occupies a striking blind spot in global dementia research. A systematic review of cognitive impairment and dementia across older populations in Asia found that research capacity and epidemiological surveillance are heavily concentrated in East Asia, leaving Central Asia with fragmented data and a significant absence of rigorous prevalence studies. This research gap is not merely an academic concern—it means that policy decisions in the region may be based on incomplete or outdated information, and that healthcare systems lack the precise burden estimates they need to plan services and allocate resources. The implications are profound.
When a disease is understudied, its true prevalence is often invisible to policymakers and the public. A nation may have lower reported dementia rates simply because fewer people are being screened, diagnosed, or included in epidemiological surveys. This creates a false reassurance that masks a potentially serious public health challenge. Central Asia’s lower Alzheimer’s disease burden (compared to East and Southeast Asia during the 1990–2021 period) cannot be interpreted as evidence of lower actual disease—it more likely reflects the absence of systematic diagnostic and surveillance infrastructure that exists in more thoroughly studied regions.
How Does Central Asia’s Dementia Burden Rank Among Other Neurological Conditions?
Within Central Asia specifically, dementia ranks fourth among neurological diseases, a position that reflects its significance but also suggests that other neurological conditions may be receiving greater attention and resources. This ranking becomes more meaningful when compared to neighboring regions: in East and Southeast Asia, dementia occupies a more prominent position in the disease burden hierarchy, driving greater policy focus, research investment, and healthcare innovation. For Central Asia, ranking fourth means that dementia often competes for limited health resources alongside stroke, epilepsy, and other neurological disorders—a competition that dementia does not always win.
However, this ranking should not be mistaken for actual disease impact. A fourth-place ranking in a region with limited overall neurological disease research is different from a fourth-place ranking in a region with sophisticated epidemiological surveillance. Central Asia’s position on this list is simultaneously accurate (in terms of current reported burden) and potentially misleading (in terms of true disease prevalence). Policymakers must recognize that future prevalence projections across Asia show a consistent upward trend in Alzheimer’s disease and other dementias over the next three decades, suggesting that Central Asia’s relative ranking may shift significantly as aging populations grow and cognitive impairment becomes more prevalent.
What Demographic and Health Factors Drive Dementia Growth Across Asia?
Asia’s aging population is the primary driver of projected dementia increases across the continent over the next 30 years. As life expectancy rises and fertility rates decline, the proportion of adults over 65—and especially over 75—increases substantially. This demographic shift is already underway in Central Asia, though at a different pace and scale than in East Asia. The World Bank’s analysis of aging in Europe and Central Asia identified healthy aging as a critical policy priority precisely because the region faces the dual challenge of rapid population aging combined with health systems that are underprepared to manage chronic conditions like dementia.
The connection between aging and dementia risk means that Central Asia cannot rely on its current lower reported disease burden as evidence that it will not face a significant cognitive impairment crisis. On the contrary, the region is vulnerable to rapid increases in dementia prevalence as cohorts of older adults expand. Without systematic screening, diagnosis, and care infrastructure in place now, Central Asia risks facing a surge in undiagnosed, untreated dementia cases in the coming decade. This is not speculation—it is a predictable consequence of aging demographics combined with current health system gaps.
What Policy Changes Are Essential to Address Cognitive Decline?
The World Bank’s analysis of aging in Europe and Central Asia emphasized that the region requires “bold adaptive action” across policy areas to support healthy aging and manage age-related diseases. This call to action reflects recognition that current health system structures and policies are inadequate for the dementia challenge ahead. Bold adaptive action means several concrete changes: shifting health systems from reactive, hospital-based care toward preventive services and early diagnostic screening; expanding training for healthcare providers in cognitive assessment and dementia diagnosis; and integrating cognitive health into primary care rather than treating it as a specialist-only concern. Currently, most Central Asian health systems are not organized for dementia screening and early intervention.
Primary care providers often lack training in cognitive assessment, diagnostic criteria go unrecognized, and patients present to healthcare systems only after dementia has progressed significantly. This represents both a tragedy for individual patients and a massive inefficiency at the population level—early detection and management of cognitive decline can slow progression, maintain independence longer, and reduce the eventual care burden on families and institutions. Shifting toward prevention and early diagnosis requires policy commitment, funding, and workforce development. The alternative is continuing on the current trajectory: a growing number of people with undiagnosed or late-stage dementia, overwhelmed caregivers, and health systems unprepared for the scale of need.
What Challenges Do Central Asian Healthcare Systems Face in Diagnosing Dementia?
Central Asian healthcare systems confront several structural barriers to effective dementia diagnosis. First, cognitive assessment tools and standardized diagnostic protocols may not be widely available or adapted to local languages and cultural contexts. A patient in Kazakhstan or Tajikistan seeking evaluation for memory loss may encounter a healthcare provider with limited training in cognitive testing and few resources for formal neuropsychological assessment. Second, the cost and logistics of diagnosis can be prohibitive—advanced imaging (MRI, PET) is not universally accessible, and specialist neurologists may be concentrated in large cities, creating geographic barriers for rural populations.
A critical limitation of current Central Asian research is that prevalence estimates may differ substantially once systematic screening programs are established. When previously undiagnosed populations are systematically screened using standardized tools, apparent prevalence rates often increase dramatically. Central Asia should anticipate that establishing better diagnostic infrastructure may reveal a dementia burden substantially higher than current estimates suggest. This is not bad news about disease incidence—it is clarifying news about how much disease has gone undetected. Health systems should prepare now for the likelihood that formal surveillance will reveal a larger true burden than epidemiological data currently indicate.
How Can Prevention and Lifestyle Factors Reduce Dementia Risk?
While Central Asia cannot prevent an aging population or reverse demographic trends, health systems and public health initiatives can substantially reduce dementia risk through prevention-focused interventions. Cardiovascular health, cognitive engagement, social connection, physical activity, sleep quality, and management of conditions like diabetes and hypertension all influence dementia risk. Countries in Central Asia that invest in public health messaging around these modifiable risk factors—particularly through primary care and community health programs—can reduce incidence and delay onset across the population.
However, prevention is only effective if it reaches the populations most at risk. In Central Asia, where healthcare access varies significantly between urban and rural areas, and where health literacy may differ by education and socioeconomic status, prevention initiatives must be deliberately designed to reach underserved populations. A prevention program available only in the capital city addresses only a fraction of the problem. Equitable, effective prevention requires investment in community health infrastructure, culturally adapted messaging, and integration of cognitive health promotion into existing primary care networks throughout the region.
What Should Central Asia Anticipate in the Coming Decades?
Across Asia broadly, the trajectory of dementia is unambiguously upward over the next 30 years. Central Asia will not be an exception to this trend. The region should anticipate increased demand for dementia diagnosis, treatment, and long-term care services; a growing proportion of healthcare resources devoted to cognitive decline; and rising caregiver burden as families manage more patients with advanced dementia. Without proactive policy and health system strengthening, this increasing demand will overwhelm existing resources.
The optimistic scenario for Central Asia involves early and decisive action: establishing research infrastructure to document actual disease burden, training healthcare providers in cognitive assessment, integrating early diagnosis into primary care, implementing prevention-focused public health initiatives, and preparing long-term care systems for increased demand. These are not speculative interventions—they are the evidence-based responses already underway in regions facing similar challenges. Central Asia has the opportunity to learn from East and Southeast Asia’s experience with rapid dementia increases and to invest in health system capacity before the crisis becomes acute. The window for this preparatory work is narrowing as aging demographics accelerate.
Conclusion
Central Asia’s dementia challenge is real, even if current epidemiological data underscore it. The region’s limited research capacity has created a false impression of lower disease burden, when in fact cognitive decline and dementia are likely far more prevalent than documented. With projections across Asia pointing consistently upward over the next three decades, and with Central Asia’s aging population accelerating, health policymakers must act now to strengthen diagnostic capacity, train healthcare providers, implement prevention programs, and prepare care systems for growing demand.
The World Bank’s call for “bold adaptive action” captures what is needed: not incremental improvements, but structural transformation of health systems toward early detection, prevention, and sustainable care for people with cognitive decline. This requires investment and commitment, but the cost of inaction—a population of increasingly disabled older adults without diagnosis or support—is far higher. Central Asia’s opportunity lies in recognizing the gap between current research and likely true disease burden, and in using that recognition to drive the policy and health system changes that will protect cognitive health across the region.
